Sir, Shapiro and Zezulka in their recent paper (1983; 50: 530-3) draw conclusions regarding the prognosis of hypertrophic cardiomyopathy, which if substantiated would greatly alter the attitude to the disease of physician and patient alike. We would suggest, however, that the data presented provide a less substantive basis for the authors' conclusions than would at first appear.
No information is given regarding the presence or absence of hypertension in the patients studied. This omission is of great Thus we suggest that inadequate information is given (a) to exclude the commonest cause of secondary ventricular hypertrophy and (b) objectively to assess the angiographic criteria which the authors used to reach a diagnosis of hypertrophic cardiomyopathy in the majority of their patients. Furthermore, when their data are examined quantitatively rather than intuitively they do not differ significantly from the prognosis previously reported.
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This letter was shown to the authors, who reply as follows:
In our study the diagnosis of hypertrophic cardiomyopathy was not based on the classical features of asymmetrical septal hypertrophy and left ventricular outflow tract obstruction but was made in the presence of left ventricular hypertrophy of unknown aetiology. Exclusion of hypertension is the greatest problem when studying hypertrophic cardiomyopathy, and a deliberate attempt was made to do this and to exclude other secondary causes of left ventricular hypertrophy.
rt!spoWInt e We would not wish to draw definitive con9Zlusions from our work but could not help by being impressed that none of our patients died during a thiee vLa:
period. We believe that this does warrant fu "the investigation and study since we agree with D --W>att and Newcombe that if other authors find iini.'-r results to our own this would greatly alter the a.--ude to the disease of both physicians and patients. 
